These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4556800)

  • 21. In vitro testing in tumor immunotherapy.
    Berkelhammer J
    Semin Oncol; 1974 Dec; 1(4):397-408. PubMed ID: 4143489
    [No Abstract]   [Full Text] [Related]  

  • 22. [Immune reactions against human malignant tumors].
    Kåresen R
    Tidsskr Nor Laegeforen; 1971 Dec; 91(35):2555-60. PubMed ID: 4109664
    [No Abstract]   [Full Text] [Related]  

  • 23. Recurrent and metastatic malignant disease: immunological considerations.
    Carter RL
    Proc R Soc Med; 1974 Sep; 67(9):852-4. PubMed ID: 4610589
    [No Abstract]   [Full Text] [Related]  

  • 24. [Immunologic study of a case of spontaneous regression of metastatic carcinoma of the portio].
    Moggian G; Barboni F; Sabetta C
    Cancro; 1974; 27(3):165-8. PubMed ID: 4465036
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical aspects of cancer immunity.
    Moore GE
    Prog Clin Cancer; 1973; 5():107-20. PubMed ID: 4571116
    [No Abstract]   [Full Text] [Related]  

  • 26. The suppressor-cell network in cancer (second of two parts).
    Broder S; Waldmann TA
    N Engl J Med; 1978 Dec; 299(24):1335-41. PubMed ID: 362202
    [No Abstract]   [Full Text] [Related]  

  • 27. In vitro methods for assessment of antibody-mediated tumor immunity.
    Levy NL; Amos DB; Solovieff GV; dos Reis AP
    Natl Cancer Inst Monogr; 1972 Dec; 35():5-11. PubMed ID: 4349154
    [No Abstract]   [Full Text] [Related]  

  • 28. [Current problems in immunology].
    Ambrosius H
    Z Gesamte Inn Med; 1974 Apr; 29(8):309-15. PubMed ID: 4137395
    [No Abstract]   [Full Text] [Related]  

  • 29. Residual cancer.
    Woodruff M
    Harvey Lect; 1971-1972; 66():161-76. PubMed ID: 4949244
    [No Abstract]   [Full Text] [Related]  

  • 30. Humoral factors in specific unresponsiveness to transplantation antigens.
    Brent L; Kilshaw PJ
    Transplant Proc; 1976 Jun; 8(2):209-15. PubMed ID: 779181
    [No Abstract]   [Full Text] [Related]  

  • 31. Cellular and humoral immune interactions during neoplastic development.
    Baldwin RW; Bowen JG; Embleton MJ; Price MR; Robins RA
    Johns Hopkins Med J Suppl; 1974; 3():393-407. PubMed ID: 4371716
    [No Abstract]   [Full Text] [Related]  

  • 32. Cell-mediated immune mechanisms of tumor cell destruction.
    Perlmann P; O'Toole C; Unsgaard B
    Fed Proc; 1973 Feb; 32(2):153-5. PubMed ID: 4540104
    [No Abstract]   [Full Text] [Related]  

  • 33. [Use of immunologic tests in cancerology].
    Cerottini JC; Mach JP; Isliker H
    Helv Chir Acta; 1973 Dec; 40(5):551-9. PubMed ID: 4589041
    [No Abstract]   [Full Text] [Related]  

  • 34. Spontaneous regression of malignant melanoma. Pathologic and immunologic study in a ten year survivor.
    Maurer H; McIntyre OR; Rueckert F
    Am J Surg; 1974 Apr; 127(4):397-403. PubMed ID: 4274502
    [No Abstract]   [Full Text] [Related]  

  • 35. Cellular and humoral factors governing canine mixed lymphocyte cultures after renal transplantation. I. Antibody.
    Miller J; Hattler B; Davis M; Johnson MC
    Transplantation; 1971 Jul; 12(1):65-76. PubMed ID: 4932699
    [No Abstract]   [Full Text] [Related]  

  • 36. [Immune surveillance in neoplasms].
    Schneeweiss U
    Z Exp Chir; 1974; 7(4):204-15. PubMed ID: 4440030
    [No Abstract]   [Full Text] [Related]  

  • 37. In vivo methods for the assessment of cell-mediated tumor immunity.
    Bartlett GL
    Natl Cancer Inst Monogr; 1972 Dec; 35():27-32. PubMed ID: 4659049
    [No Abstract]   [Full Text] [Related]  

  • 38. [Factors of bodily resistance and metastasis].
    Maĭskiĭ IN; Lomakin MS
    Usp Sovrem Biol; 1976; 82(4):63-76. PubMed ID: 790816
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunopathology of viral hepatitis in man.
    Reed WD; Eddleston AL; Williams R
    Prog Med Virol; 1974; 17(0):38-76. PubMed ID: 4153910
    [No Abstract]   [Full Text] [Related]  

  • 40. Inhibition of effector cell function in human antibody-dependent cellular cytotoxicity by sera from cancer patients.
    Mikulski SM; Billing R; Terasaki PI
    J Natl Cancer Inst; 1977 May; 58(5):1485-7. PubMed ID: 857035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.